These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6240879)

  • 1. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
    Szarvas Z; Zsolnai B
    Acta Chir Hung; 1984; 25(4):269-76. PubMed ID: 6240879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
    [No Abstract]   [Full Text] [Related]  

  • 4. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
    Szarvas Z; Zsolnai B
    Zentralbl Gynakol; 1984; 106(14):1010-7. PubMed ID: 6239468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous, high-dose progestogen treatment of endometrial cancer.
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Gynecol Obstet Invest; 1987; 24(4):262-6. PubMed ID: 2962910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
    Szarvas Z; Zsolnai B
    Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemical examinations of Ca, cytochrome oxidase and succinate dehydrogenase enzymes in endometrium carcinomatous tissue after high dose progestogen treatment.
    Szarvas Z; Balogh I; Patai K
    Acta Morphol Hung; 1988; 36(3-4):177-83. PubMed ID: 2855777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to Dr. Edwin B. McDaniel. Exaggerated claims of depo-provera safety.
    Minkin SF
    Women Health; 1981; 6(1-2):125-9. PubMed ID: 6223451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
    Okada H; Nakata Y; Fujimoto J; Fujita H
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2837-44. PubMed ID: 2959204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth of endometrial cancer and hormone].
    Kanoh H; Hosono T; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma.
    Piver MS; Barlow JJ; Lurain JR; Blumenson LE
    Cancer; 1980 Jan; 45(2):268-72. PubMed ID: 6985833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
    Balogh F; Romics I
    Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of drug treatment of endometrial carcinoma].
    Schulz KD; Kaiser R
    Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
    Ohta M; Takeda A; Ninagawa T; Tomoda Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
    [No Abstract]   [Full Text] [Related]  

  • 18. Depo-Provera: an injectable contraceptive.
    Wigington S
    Nurs Times; 1981 Oct 14-20; 77(42):1794-8. PubMed ID: 6458020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
    Macdonald RR; Thorogood J; Mason MK
    Br J Obstet Gynaecol; 1988 Feb; 95(2):166-74. PubMed ID: 2964861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.